Robert Berman, Special Projects & Med Ovrsght at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 124,700 shares at $54.89 ($6.6M) on 2019-12-30, disclosed to the SEC on 2019-12-31.
Open-market sale of $6.6M BHVN by Special Projects & Med Ovrsght. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.95 | 67,450 | $3.6M | 53.8% |
| 2 | $53.43 | 53,762 | $2.9M | 43.3% |
| 3 | $54.89 | 3,488 | $191K | 2.9% |
| Total | $53.21 avg | 124,700 | $6.6M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $6.4M | — | Filing → |